Health-Related Quality of Life (HRQoL) and Changes in Work Productivity Measures with Subcutaneous C1-Inhibitor [C1-INH(SC)] for the Prevention of Hereditary Angioedema (HAE) Attacks: Findings from the Compact Study

被引：1
|
作者：
Lumry, William [1 ]
Craig, Timothy J. [2 ]
Farkas, Henriette [3 ]
Feuersenger, Henrike [4 ,5 ]
机构：
[1] AARA Res Ctr, Dallas, TX USA
[2] Penn State Univ, Hershey Med Ctr, Hershey, PA USA
[3] Semmelweis Univ, Budapest, Hungary
[4] CSL Behring, Marburg, Germany
[5] CSL Behring, King Of Prussia, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.751
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
732
引用
收藏
页码：AB233 / AB233
页数：1
相关论文
共 50 条
  • [31] Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema
    Pawaskar, Dipti
    Tortorici, Michael A.
    Zuraw, Bruce
    Craig, Timothy
    Cicardi, Marco
    Longhurst, Hilary
    Li, H. Henry
    Lumry, William R.
    Martinez-Saguer, Inmaculada
    Jacobs, Joshua
    Bernstein, Jonathan A.
    Riedl, Marc A.
    Katelaris, Constance H.
    Keith, Paul K.
    Feussner, Annette
    Sidhu, Jagdev
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (10): : 1325 - 1332
  • [32] Subcutaneous (SC) vs Intravenous (IV) C1-esterase-inhibitor (C1-INH) Replacement Treatment For The Prevention Of Attacks Of Hereditary Angioedema (HAE): A Population-based Exposure-response Analysis
    Zuraw, Bruce L.
    Cicardi, Marco
    Craig, Timothy J.
    Longhurst, Hilary J.
    Lumry, William R.
    Bernstein, Jonathan A.
    Zhang, Ying
    Pawaskar, Dipti K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB52 - AB52
  • [33] COMPARATIVE-ANALYSIS OF C1-INHIBITOR (C1-INH) FUNCTION VERSUS CONCENTRATION IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE) AND OTHER IMMUNOLOGICAL DISORDERS
    SPAETH, PJ
    BUETLER, R
    NYDEGGER, U
    IMMUNOBIOLOGY, 1981, 160 (01) : 114 - 114
  • [34] Health-Related Quality Of Life (HRQoL) In Adult Patients With Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1-INH) Assessed By SF-36v2
    Caballero, Teresa
    Julia Caminoa, Magdalena
    Perez-Fernandez, Elia
    Gomez-Traseira, Carmen
    Aabom, Anne
    Aberer, Werner
    Betschel, Stephen D.
    Bygum, Anette
    Csuka, Dorottya
    Farkas, Henriette
    Gomide, Maria
    Groffik, Adriane
    Grumach, Anete S.
    Leivobich, Iris
    Malbran, Alejandro
    Mihaly, Eniko
    Moldovan, Dumitru
    Obtulowicz, Krystyna
    Porebski, Gregor
    Rayonne, Celina
    Reshef, Avner
    Staubach, Petra
    Wiednig, Michaela
    Joao Forjaz, Maria
    Prior, Nieves
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB34 - AB34
  • [35] The influence of individualized treatment on the quality of life (QoL) in 100 patients with Hereditary Angioedema (HAE C1-INH)
    Saguer, Inmaculada Martinez
    Ettingshausen, Carmen Escuriola
    Gutowski, Zeynep
    Linde, Richard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB51 - AB51
  • [36] PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS VERSUS INTRAVENOUS C1-INHIBITOR FOR THE PREVENTION OF HEREDITARY ANGIOEDEMA ATTACKS
    Zuraw, B.
    Cicardi, M.
    Craig, T.
    Lumry, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S40 - S40
  • [37] PATIENTS RECEIVING C1-INH TREATMENT FOR HEREDITARY ANGIOEDEMA REPORT FEW HEALTH-RELATED LIMITATIONS ON QUALITY OF LIFE SURVEY
    Bewtra, A.
    Levy, R.
    Wasserman, R.
    Jacobson, K.
    Craig, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A115 - A115
  • [38] Response to subcutaneous human C1-Inhibitor for the prevention of angioedema attacks in patients with hereditary angioedema: subgroups based on prior intravenous C1-inhibitor use
    Magerl, M.
    Bernstein, J. A.
    Banerji, A.
    Li, H. H.
    Lumry, W. R.
    Maurer, M.
    Riedl, M.
    Chen, H.
    Schranz, J.
    ALLERGY, 2015, 70 : 60 - 60
  • [39] Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (vol 16, 86, 2021)
    Lumry, William R.
    Zuraw, Bruce
    Cicardi, Marco
    Craig, Timothy
    Anderson, John
    Banerji, Aleena
    Bernstein, Jonathan A.
    Caballero, Teresa
    Farkas, Henriette
    Gower, Richard G.
    Keith, Paul K.
    Levy, Donald S.
    Li, H. Henry
    Magerl, Markus
    Manning, Michael
    Riedl, Marc A.
    Lawo, John-Philip
    Prusty, Subhransu
    Machnig, Thomas
    Longhurst, Hilary
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [40] Improved health-related quality of life in pediatric patients with hereditary angioedema (HAE): a phase 3 study of C1 inhibitor for attack prevention
    Martinez-Saguer, I
    Soteres, D.
    Van Leerberghe, A.
    Herrera, E. M.
    Devercelli, G.
    Vardi, M.
    Christensen, J.
    ALLERGY, 2018, 73 : 718 - 718
12345